• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

爱泼斯坦-巴尔病毒的血清Zta抗体在鼻咽癌诊断中发挥潜在作用。

Serum Zta antibody of Epstein-Barr virus exerts potential function in the diagnosis of nasopharyngeal cancer.

作者信息

Zhang Xiaoyan, Zhang Yun, Nie Yunqiang, Wang Shoufeng, Chen Yanlin, Sun Dezhong

机构信息

Department of Medicine Oncology, Linyi City People's Hospital, Linyi, 276000, China.

出版信息

Tumour Biol. 2014 Jul;35(7):6879-86. doi: 10.1007/s13277-014-1940-y. Epub 2014 Apr 16.

DOI:10.1007/s13277-014-1940-y
PMID:24737587
Abstract

The diagnosis of nasopharyngeal cancer (NPC) remains a clinical challenge. Many studies have assessed the diagnostic potential of Zta antibody of the Epstein-Barr virus (EBV) in NPC patients but with controversial results. This study aims to summarize the overall diagnostic performance of EBV Zta antibody in NPC. Based on a comprehensive search of the Pubmed and Embase, Web of Science, Chinese National Knowledge Infrastructure (CNKI), Wanfang Databases and China Citation Databases, we identified outcome data from all articles estimating diagnostic accuracy of EBV Zta antibody for NPC. A summary estimation for sensitivity, specificity, and other diagnostic indexes were pooled using a bivariate model. The overall measure of accuracy was calculated using summary receiver operating characteristic curve and the area under curve (AUC) was calculated. According to our inclusion criteria, 17 studies with 11,822 subjects (1,645 NPC cases, 10,177 controls) were included. The summary estimates were: sensitivity 0.87 (95 % confidence interval [CI] = 0.86-0.89), specificity 0.94 (95 % CI = 0.93-0.94), positive likelihood ratio 8.05 (95 % CI = 5.59-11.59), negative likelihood ratio 0.16 (95 % CI = 0.12-0.21), diagnostic odds ratio 52.93 (95 % CI = 29.95-93.56), the AUC and Q* index were 0.9352 and 0.8714, respectively. In conclusion, serum EBV Zta had a better diagnostic performance for NPC. Further studies should be performed to confirm our findings.

摘要

鼻咽癌(NPC)的诊断仍然是一项临床挑战。许多研究评估了爱泼斯坦-巴尔病毒(EBV)Zta抗体在NPC患者中的诊断潜力,但结果存在争议。本研究旨在总结EBV Zta抗体在NPC中的总体诊断性能。通过全面检索PubMed、Embase、Web of Science、中国知网(CNKI)、万方数据库和中国引文数据库,我们从所有评估EBV Zta抗体对NPC诊断准确性的文章中确定了结果数据。使用双变量模型汇总敏感性、特异性和其他诊断指标的汇总估计值。使用汇总的受试者工作特征曲线计算总体准确性指标,并计算曲线下面积(AUC)。根据我们的纳入标准,纳入了17项研究,共11822名受试者(1645例NPC病例,10177例对照)。汇总估计值为:敏感性0.87(95%置信区间[CI]=0.86-0.89),特异性0.94(95%CI=0.93-0.94),阳性似然比8.05(95%CI=5.59-11.59),阴性似然比0.16(95%CI=0.12-0.21),诊断比值比52.93(95%CI=29.95-93.56),AUC和Q*指数分别为0.9352和0.8714。总之,血清EBV Zta对NPC具有较好的诊断性能。应进行进一步研究以证实我们的发现。

相似文献

1
Serum Zta antibody of Epstein-Barr virus exerts potential function in the diagnosis of nasopharyngeal cancer.爱泼斯坦-巴尔病毒的血清Zta抗体在鼻咽癌诊断中发挥潜在作用。
Tumour Biol. 2014 Jul;35(7):6879-86. doi: 10.1007/s13277-014-1940-y. Epub 2014 Apr 16.
2
Clinical value of serum Epstein-Barr virus DNA assay in the diagnosis of nasopharyngeal carcinoma.血清爱泼斯坦-巴尔病毒DNA检测在鼻咽癌诊断中的临床价值
Tumour Biol. 2014 Sep;35(9):8787-93. doi: 10.1007/s13277-014-2148-x. Epub 2014 May 31.
3
Diagnostic Value of Serum Epstein-Barr Virus Capsid Antigen-IgA for Nasopharyngeal Carcinoma: a Meta-Analysis Based on 21 Studies.血清爱泼斯坦-巴尔病毒衣壳抗原-IgA对鼻咽癌的诊断价值:一项基于21项研究的Meta分析
Clin Lab. 2016;62(6):1155-66. doi: 10.7754/clin.lab.2015.151122.
4
Study on sero-diagnosis of nasopharyngeal carcinoma using a dual antibody test against recombinant Epstein-Barr virus antigens.利用抗重组爱泼斯坦-巴尔病毒抗原的双抗体检测法进行鼻咽癌血清学诊断的研究。
Ai Zheng. 2003 Sep;22(9):903-6.
5
[Six anti-Epstein-Barr virus antibodies in healthy adults in a high risk area of nasopharyngeal carcinoma].[鼻咽癌高风险地区健康成年人中的六种抗爱泼斯坦-巴尔病毒抗体]
Ai Zheng. 2009 Aug;28(8):822-6. doi: 10.5732/cjc.009.10095.
6
EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.基于EBV特异性抗体和DNA检测在鼻咽癌血清学诊断中的应用
Int J Cancer. 2003 Jul 10;105(5):706-9. doi: 10.1002/ijc.11130.
7
Application of logistic regression in combination with multiple diagnostic tests for auxiliary diagnosis of nasopharyngeal carcinoma.逻辑回归结合多项诊断测试在鼻咽癌辅助诊断中的应用。
Ai Zheng. 2009 Feb;28(2):177-80. Epub 2009 Feb 15.
8
A Randomized Controlled Trial on Evaluation of Plasma Epstein-Barr Virus Biomarker for Early Diagnosis in Patients With Nasopharyngeal Carcinoma.一项评估血浆 Epstein-Barr 病毒标志物用于鼻咽癌患者早期诊断的随机对照试验。
Adv Ther. 2020 Oct;37(10):4280-4290. doi: 10.1007/s12325-020-01461-4. Epub 2020 Aug 11.
9
Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.用于鼻咽癌筛查和风险评估的 Epstein-Barr 病毒血清学工具的比较:一项大型基于人群的研究。
Pathol Oncol Res. 2020 Oct;26(4):2185-2190. doi: 10.1007/s12253-020-00808-0. Epub 2020 Mar 28.
10
Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum.基于EB病毒抗体谱评估鼻咽癌风险。
Int J Cancer. 2002 Feb 1;97(4):489-92. doi: 10.1002/ijc.1641.

引用本文的文献

1
Establishment and validation of a two-step screening scheme for improved performance of serological screening of nasopharyngeal carcinoma.建立和验证两步筛选方案,以提高鼻咽癌血清学筛查的性能。
Cancer Med. 2018 Apr;7(4):1458-1467. doi: 10.1002/cam4.1345. Epub 2018 Feb 25.
2
Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus Zta IgA antibodies in human serum.人血清中EB病毒Zta IgA抗体时间分辨荧光免疫分析方法的建立。
Viral Immunol. 2015 Apr;28(3):179-83. doi: 10.1089/vim.2014.0126. Epub 2015 Feb 4.

本文引用的文献

1
Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics.使用标准和广义 Q 统计量对 RCT 的荟萃分析进行异质性的量化、展示和解释。
BMC Med Res Methodol. 2011 Apr 7;11:41. doi: 10.1186/1471-2288-11-41.
2
Breast tomosynthesis in clinical practice: initial results.乳腺断层合成在临床实践中的初步结果。
Eur Radiol. 2010 Jan;20(1):16-24. doi: 10.1007/s00330-009-1523-2. Epub 2009 Aug 6.
3
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
用于报告评估医疗保健干预措施的系统评价和荟萃分析的PRISMA声明:解释与详述
BMJ. 2009 Jul 21;339:b2700. doi: 10.1136/bmj.b2700.
4
Application of logistic regression in combination with multiple diagnostic tests for auxiliary diagnosis of nasopharyngeal carcinoma.逻辑回归结合多项诊断测试在鼻咽癌辅助诊断中的应用。
Ai Zheng. 2009 Feb;28(2):177-80. Epub 2009 Feb 15.
5
Systematic reviews of diagnostic test accuracy.诊断试验准确性的系统评价。
Ann Intern Med. 2008 Dec 16;149(12):889-97. doi: 10.7326/0003-4819-149-12-200812160-00008.
6
Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro.爱泼斯坦-巴尔病毒编码的EBNA1调节鼻咽癌细胞中的AP-1转录因子途径并在体外增强血管生成。
J Gen Virol. 2008 Nov;89(Pt 11):2833-2842. doi: 10.1099/vir.0.2008/003392-0.
7
[Comparison of IgA/VCA, IgA/EA, IgG/EA in immunoenzyme methods and ZEBRA ELISA in early diagnosis of nasopharyngeal carcinoma.].免疫酶法中IgA/VCA、IgA/EA、IgG/EA及斑马鱼酶联免疫吸附测定法在鼻咽癌早期诊断中的比较。
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2006 Sep;20(3):263-5.
8
The enigmatic epidemiology of nasopharyngeal carcinoma.鼻咽癌的神秘流行病学。
Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1765-77. doi: 10.1158/1055-9965.EPI-06-0353.
9
Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer.诊断与筛查试验准确性评估的Meta分析:方法学入门
AJR Am J Roentgenol. 2006 Aug;187(2):271-81. doi: 10.2214/AJR.06.0226.
10
Meta-DiSc: a software for meta-analysis of test accuracy data.Meta-DiSc:一款用于检验准确性数据荟萃分析的软件。
BMC Med Res Methodol. 2006 Jul 12;6:31. doi: 10.1186/1471-2288-6-31.